BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22974322)

  • 1. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.
    Santos C; López-Doriga A; Navarro M; Mateo J; Biondo S; Martínez Villacampa M; Soler G; Sanjuan X; Paules MJ; Laquente B; Guinó E; Kreisler E; Frago R; Germà JR; Moreno V; Salazar R
    Colorectal Dis; 2013 Apr; 15(4):414-22. PubMed ID: 22974322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
    Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
    Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients.
    Chen TC; Wang CP; Ko JY; Yang TL; Hsu CW; Yeh KA; Chang YL; Lou PJ
    Ann Surg Oncol; 2013 Jul; 20(7):2388-95. PubMed ID: 23361897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of perineural invasion in early-stage cervical cancer.
    Elsahwi KS; Barber E; Illuzzi J; Buza N; Ratner E; Silasi DA; Santin AD; Azodi M; Schwartz PE; Rutherford TJ
    Gynecol Oncol; 2011 Dec; 123(3):561-4. PubMed ID: 21968340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer.
    Yilmaz A; Duyar SS; Cakir E; Aydin E; Demirag F; Karakaya J; Yazici U; Erdogan Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):664-70. PubMed ID: 21334917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
    Gertler R; Rosenberg R; Schuster T; Friess H
    Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Stratification in Patients with Stage II Colon Cancer.
    Amri R; England J; Bordeianou LG; Berger DL
    Ann Surg Oncol; 2016 Nov; 23(12):3907-3914. PubMed ID: 27380640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
    Liska D; Stocchi L; Karagkounis G; Elagili F; Dietz DW; Kalady MF; Kessler H; Remzi FH; Church J
    Ann Surg Oncol; 2017 Apr; 24(4):1093-1099. PubMed ID: 27812826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
    O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
    J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
    Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
    J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.
    Sánchez-Velázquez P; Pera M; Jiménez-Toscano M; Mayol X; Rogés X; Lorente L; Iglesias M; Gallén M
    Clin Transl Oncol; 2018 Oct; 20(10):1321-1328. PubMed ID: 29623587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.